• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型乳酸铝与基于氯化铝的止汗剂在过度腋下出汗中的比较:首个前瞻性队列研究。

Comparison of novel aluminium lactate versus aluminium chloride-based antiperspirant in excessive axillary perspiration: First prospective cohort study.

机构信息

Dermatologikum Hamburg GmbH, Hamburg, Germany.

Department of Dermatology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Dermatol Ther. 2021 Jul;34(4):e15020. doi: 10.1111/dth.15020. Epub 2021 Jun 29.

DOI:10.1111/dth.15020
PMID:34085372
Abstract

Aluminium chloride-based antiperspirants are an effective topical therapeutic option for mild to moderate states of excessive perspiration. Its use is primarily limited by the occurrence of skin irritation, especially in sensitive skin types. The objective of this study was to compare the antiperspirant efficacy and tolerability of a novel antiperspirant with 12.5% aluminium lactate, and a 12.5% aluminium chloride-based antiperspirant. This cohort study was conducted as a two-sided self-assessment comparison between both preparations in healthy volunteers to generate selfcare-related data. Almost half of the participants stated that aluminium chloride was more efficacious than aluminium lactate; 22% stated aluminium lactate was more efficacious than aluminium chloride; 28% observed no difference in the efficacy of both preparations (p = 0.04). However, 88% described greater tolerability with aluminium lactate (p < 0.0001). In this study, aluminium lactate showed significantly greater tolerability than aluminium chloride, although the latter tended to show slightly greater efficacy.

摘要

基于氯化铝的止汗剂是治疗轻中度过度出汗的有效局部治疗选择。其使用主要受到皮肤刺激的发生限制,特别是在敏感皮肤类型中。本研究的目的是比较新型含 12.5%乳酸铝和 12.5%氯化铝的止汗剂的止汗效果和耐受性。这项队列研究是在健康志愿者中进行的,采用双侧自我评估比较两种制剂,以生成自我护理相关数据。近一半的参与者表示氯化铝比乳酸铝更有效;22%的参与者表示乳酸铝比氯化铝更有效;28%的参与者观察到两种制剂的疗效没有差异(p=0.04)。然而,88%的参与者表示乳酸铝的耐受性更好(p<0.0001)。在这项研究中,乳酸铝的耐受性明显优于氯化铝,尽管后者的疗效略有增加。

相似文献

1
Comparison of novel aluminium lactate versus aluminium chloride-based antiperspirant in excessive axillary perspiration: First prospective cohort study.新型乳酸铝与基于氯化铝的止汗剂在过度腋下出汗中的比较:首个前瞻性队列研究。
Dermatol Ther. 2021 Jul;34(4):e15020. doi: 10.1111/dth.15020. Epub 2021 Jun 29.
2
Comparison of a novel aluminum lactate-based with an aluminum chloride-based antiperspirant in excessive axillary and inguinal perspiration: first randomized controlled trial.新型乳酸铝制剂与氯化铝制剂止汗剂治疗过度腋窝和腹股沟多汗的比较:首个随机对照试验。
J Dtsch Dermatol Ges. 2022 Dec;20(12):1589-1601. doi: 10.1111/ddg.14898. Epub 2022 Dec 10.
3
[Axillary hyperhidrosis--efficacy and tolerability of an aluminium chloride antiperspirant. Prospective evaluation on 20 patients with idiopathic axillary hyperhidrosis].[腋窝多汗症——氯化铝止汗剂的疗效和耐受性。对20例特发性腋窝多汗症患者的前瞻性评估]
Hautarzt. 2010 Feb;61(2):139-44. doi: 10.1007/s00105-009-1841-y.
4
Clinical studies of sweat rate reduction by an over-the-counter soft-solid antiperspirant and comparison with a prescription antiperspirant product in male panelists.临床研究表明,一种非处方的软固态止汗剂可以减少出汗量,并与男性志愿者使用的处方止汗剂产品进行了比较。
Br J Dermatol. 2012 Mar;166 Suppl 1:22-6. doi: 10.1111/j.1365-2133.2011.10786.x.
5
Hyperhidrosis plantaris - a randomized, half-side trial for efficacy and safety of an antiperspirant containing different concentrations of aluminium chloride.足底多汗症——一种止汗剂的随机、半侧试验,评估不同浓度氯化铝的疗效和安全性。
J Dtsch Dermatol Ges. 2012 Feb;10(2):115-9. doi: 10.1111/j.1610-0387.2011.07750.x. Epub 2011 Aug 16.
6
Quantitative ion determination in eccrine sweat gland cells correlates to sweat reduction of antiperspirant actives.定量测定外分泌汗腺细胞中的离子与止汗活性物质的减少汗液分泌相关。
Int J Cosmet Sci. 2021 Apr;43(2):181-190. doi: 10.1111/ics.12679. Epub 2021 Jan 1.
7
Long-Term Use of Antiperspirant is Associated with a Low Risk of Postoperative Complications in Patients with Axillary Osmidrosis.长期使用止汗剂与腋窝臭汗症患者术后并发症的低风险相关。
Clin Cosmet Investig Dermatol. 2022 Oct 30;15:2335-2343. doi: 10.2147/CCID.S381380. eCollection 2022.
8
Influence of climatic conditions on antiperspirant efficacy determined at different test areas.气候条件对在不同测试区域测定的止汗剂功效的影响。
Skin Res Technol. 2008 May;14(2):213-9. doi: 10.1111/j.1600-0846.2007.00282.x.
9
Randomized control trial: evaluating aluminum-based antiperspirant use, axilla skin toxicity, and reported quality of life in women receiving external beam radiotherapy for treatment of Stage 0, I, and II breast cancer.随机对照试验:评估女性在接受乳腺癌 0 期、I 期和 II 期外照射放疗时使用含铝止汗剂、腋窝皮肤毒性和报告的生活质量。
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e29-34. doi: 10.1016/j.ijrobp.2011.12.006.
10
Structure-Function Correlations in the Mechanism of Action of Key Antiperspirant Agents Containing Al(III) and ZAG Salts.含 Al(III)和 ZAG 盐的止汗剂作用机制的结构-功能关系。
ACS Appl Mater Interfaces. 2022 Mar 9;14(9):11597-11609. doi: 10.1021/acsami.1c22771. Epub 2022 Feb 25.

引用本文的文献

1
A Retrospective Cohort Study Comparing the Clinical Outcomes of the Hydrosurgery System and Traditional Single-Incision Surgery for Axillary Osmidrosis.一项比较水刀手术系统与传统单切口手术治疗腋臭临床疗效的回顾性队列研究。
J Cosmet Dermatol. 2025 Jan;24(1):e16755. doi: 10.1111/jocd.16755.
2
Advances in the treatment of axillary bromhidrosis.腋窝多汗症治疗方法的新进展。
Skin Res Technol. 2024 Aug;30(8):e13895. doi: 10.1111/srt.13895.
3
Deodorants and antiperspirants: New trends in their active agents and testing methods.除臭剂和止汗剂:其活性成分和测试方法的新趋势。
Int J Cosmet Sci. 2023 Aug;45(4):426-443. doi: 10.1111/ics.12852. Epub 2023 Mar 21.